MYC Degradation

被引:379
作者
Farrell, Amy S. [1 ]
Sears, Rosalie C. [1 ]
机构
[1] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA
关键词
PROLYL ISOMERASE PIN1; REGULATES C-MYC; TUMOR-SUPPRESSOR; BREAST-CANCER; DNA-BINDING; TRANSCRIPTIONAL ACTIVATION; PROTEIN-DEGRADATION; HISTONE DEACETYLASE; INDUCED SENESCENCE; CELL-GROWTH;
D O I
10.1101/cshperspect.a014365
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
100103 [病原生物学]; 100218 [急诊医学];
摘要
The MYC oncoprotein is an essential transcription factor that regulates the expression of many genes involved in cell growth, proliferation, and metabolic pathways. Thus, it is important to keep MYC activity in check in normal cells in order to avoid unwanted oncogenic changes. Normal cells have adapted several ways to control MYC levels, and these mechanisms can be disrupted in cancer cells. One of the major ways in which MYC levels are controlled in cells is through targeted degradation by the ubiquitin-proteasome system (UPS). Here, we discuss the role of the UPS in the regulation of MYC protein levels and review some of the many proteins that have been shown to regulate MYC protein stability. In addition, we discuss how this relates to MYC transcriptional activity, human cancers, and therapeutic targeting.
引用
收藏
页数:15
相关论文
共 120 条
[1]
The ubiquitin ligase HectH9 regulates transcriptional activation by myc and is essential for tumor cell proliferation [J].
Adhikary, S ;
Marinoni, F ;
Hock, A ;
Hulleman, E ;
Popov, N ;
Beier, R ;
Bernard, S ;
Quarto, M ;
Capra, M ;
Goettig, S ;
Kogel, U ;
Scheffner, M ;
Helin, K ;
Eilers, M .
CELL, 2005, 123 (03) :409-421
[2]
FBXW7/hCDC4 is a general tumor suppressor in human cancer [J].
Akhoondi, Shahab ;
Sun, Dahui ;
von der Lehr, Natalie ;
Apostolidou, Sophia ;
Klotz, Kathleen ;
Maljukova, Alena ;
Cepeda, Diana ;
Fiegl, Heidi ;
Dofou, Dimitra ;
Marth, Christian ;
Mueller-Holzner, Elisabeth ;
Corcoran, Martin ;
Dagnell, Markus ;
Nejad, Sepideh Zabihi ;
Nayer, Babak Noori ;
Zali, Mohammad Reza ;
Hansson, Johan ;
Egyhazi, Susanne ;
Petersson, Fredrik ;
Sangfelt, Per ;
Nordgren, Hans ;
Grander, Dan ;
Reed, Steven I. ;
Widschwendter, Martin ;
Sangfelt, Olle ;
Spruck, Charles .
CANCER RESEARCH, 2007, 67 (19) :9006-9012
[3]
Protein phosphatase 2A regulatory subunit b56α associates with c-Myc and negatively regulates c-Myc accumulation [J].
Arnold, HK ;
Sears, RC .
MOLECULAR AND CELLULAR BIOLOGY, 2006, 26 (07) :2832-2844
[4]
The Axin1 scaffold protein promotes formation of a degradation complex for c-Myc [J].
Arnold, Hugh K. ;
Zhang, Xiaoli ;
Daniel, Colin J. ;
Tibbitts, Deanne ;
Escamilla-Powers, Julie ;
Farrell, Amy ;
Tokarz, Sara ;
Morgan, Charlie ;
Sears, Rosalie C. .
EMBO JOURNAL, 2009, 28 (05) :500-512
[5]
Ayala G, 2003, CANCER RES, V63, P6244
[6]
Getting at MYC through RAS [J].
Bachireddy, P ;
Bendapudi, PK ;
Felsher, DW .
CLINICAL CANCER RESEARCH, 2005, 11 (12) :4278-4281
[7]
c-Myc hot spot mutations in lymphomas result in inefficient ubiquitination and decreased proteasome-mediated turnover [J].
Bahram, F ;
von der Lehr, N ;
Cetinkaya, C ;
Larsson, LG .
BLOOD, 2000, 95 (06) :2104-2110
[8]
Ballinger CA, 1999, MOL CELL BIOL, V19, P4535
[9]
POINT MUTATIONS IN THE C-MYC TRANSACTIVATION DOMAIN ARE COMMON IN BURKITTS-LYMPHOMA AND MOUSE PLASMACYTOMAS [J].
BHATIA, K ;
HUPPI, K ;
SPANGLER, G ;
SIWARSKI, D ;
IYER, R ;
MAGRATH, I .
NATURE GENETICS, 1993, 5 (01) :56-61
[10]
MAX - A HELIX-LOOP-HELIX ZIPPER PROTEIN THAT FORMS A SEQUENCE-SPECIFIC DNA-BINDING COMPLEX WITH MYC [J].
BLACKWOOD, EM ;
EISENMAN, RN .
SCIENCE, 1991, 251 (4998) :1211-1217